Answer
The most common adverse reactions to leniolisib phosphate (Joenja) in patients with APDS were headache, sinusitis and atopic dermatitis, each occurring in more than 10% of patients.
Sources for this answer
- Joenja 70 mg Film-coated tabletsPharming Technologies B.V. · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked